126 related articles for article (PubMed ID: 27072566)
1. Regulation of Runx2 by Histone Deacetylases in Bone.
Vishal M; Ajeetha R; Keerthana R; Selvamurugan N
Curr Protein Pept Sci; 2016; 17(4):343-51. PubMed ID: 27072566
[TBL] [Abstract][Full Text] [Related]
2. Regulation of Histone Deacetylases by MicroRNAs in Bone.
Shreya S; Malavika D; Priya VR; Selvamurugan N
Curr Protein Pept Sci; 2019; 20(4):356-367. PubMed ID: 30381072
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase co-repressor complex control of Runx2 and bone formation.
Jensen ED; Nair AK; Westendorf JJ
Crit Rev Eukaryot Gene Expr; 2007; 17(3):187-96. PubMed ID: 17725488
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase 8 suppresses osteogenic differentiation of bone marrow stromal cells by inhibiting histone H3K9 acetylation and RUNX2 activity.
Fu Y; Zhang P; Ge J; Cheng J; Dong W; Yuan H; Du Y; Yang M; Sun R; Jiang H
Int J Biochem Cell Biol; 2014 Sep; 54():68-77. PubMed ID: 25019367
[TBL] [Abstract][Full Text] [Related]
5. Histone deacetylase 7 associates with Runx2 and represses its activity during osteoblast maturation in a deacetylation-independent manner.
Jensen ED; Schroeder TM; Bailey J; Gopalakrishnan R; Westendorf JJ
J Bone Miner Res; 2008 Mar; 23(3):361-72. PubMed ID: 17997710
[TBL] [Abstract][Full Text] [Related]
6. Bone morphogenetic protein-2 stimulates Runx2 acetylation.
Jeon EJ; Lee KY; Choi NS; Lee MH; Kim HN; Jin YH; Ryoo HM; Choi JY; Yoshida M; Nishino N; Oh BC; Lee KS; Lee YH; Bae SC
J Biol Chem; 2006 Jun; 281(24):16502-11. PubMed ID: 16613856
[TBL] [Abstract][Full Text] [Related]
7. Chemical and genetic blockade of HDACs enhances osteogenic differentiation of human adipose tissue-derived stem cells by oppositely affecting osteogenic and adipogenic transcription factors.
Maroni P; Brini AT; Arrigoni E; de Girolamo L; Niada S; Matteucci E; Bendinelli P; Desiderio MA
Biochem Biophys Res Commun; 2012 Nov; 428(2):271-7. PubMed ID: 23085045
[TBL] [Abstract][Full Text] [Related]
8. Ratjadone C-mediated nuclear accumulation of HDAC4: implications on Runx2-induced osteoblast differentiation of C3H10T1/2 mesenchymal stem cells.
Mu P; Deepak V; Kang L; Jiang Q; Liu R; Meng L; Zhang Z; Zeng X; Liu W
Z Naturforsch C J Biosci; 2014; 69(11-12):471-8. PubMed ID: 25854767
[TBL] [Abstract][Full Text] [Related]
9. HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms.
Manzotti G; Torricelli F; Donati B; Sancisi V; Gugnoni M; Ciarrocchi A
J Exp Clin Cancer Res; 2019 Aug; 38(1):346. PubMed ID: 31395086
[TBL] [Abstract][Full Text] [Related]
10. microRNA-103a functions as a mechanosensitive microRNA to inhibit bone formation through targeting Runx2.
Zuo B; Zhu J; Li J; Wang C; Zhao X; Cai G; Li Z; Peng J; Wang P; Shen C; Huang Y; Xu J; Zhang X; Chen X
J Bone Miner Res; 2015 Feb; 30(2):330-45. PubMed ID: 25195535
[TBL] [Abstract][Full Text] [Related]
11. Regulation of Runx2 by MicroRNAs in osteoblast differentiation.
Narayanan A; Srinaath N; Rohini M; Selvamurugan N
Life Sci; 2019 Sep; 232():116676. PubMed ID: 31340165
[TBL] [Abstract][Full Text] [Related]
12. Hdac-mediated control of endochondral and intramembranous ossification.
Bradley EW; McGee-Lawrence ME; Westendorf JJ
Crit Rev Eukaryot Gene Expr; 2011; 21(2):101-13. PubMed ID: 22077150
[TBL] [Abstract][Full Text] [Related]
13. HOXA10 controls osteoblastogenesis by directly activating bone regulatory and phenotypic genes.
Hassan MQ; Tare R; Lee SH; Mandeville M; Weiner B; Montecino M; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Mol Cell Biol; 2007 May; 27(9):3337-52. PubMed ID: 17325044
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Signatures at the RUNX2-P1 and Sp7 Gene Promoters Control Osteogenic Lineage Commitment of Umbilical Cord-Derived Mesenchymal Stem Cells.
Sepulveda H; Aguilar R; Prieto CP; Bustos F; Aedo S; Lattus J; van Zundert B; Palma V; Montecino M
J Cell Physiol; 2017 Sep; 232(9):2519-2527. PubMed ID: 27689934
[TBL] [Abstract][Full Text] [Related]
15. Runx2/DICER/miRNA Pathway in Regulating Osteogenesis.
Zheng L; Tu Q; Meng S; Zhang L; Yu L; Song J; Hu Y; Sui L; Zhang J; Dard M; Cheng J; Murray D; Tang Y; Lian JB; Stein GS; Chen J
J Cell Physiol; 2017 Jan; 232(1):182-91. PubMed ID: 27064596
[TBL] [Abstract][Full Text] [Related]
16. The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption.
Iezaki T; Onishi Y; Ozaki K; Fukasawa K; Takahata Y; Nakamura Y; Fujikawa K; Takarada T; Yoneda Y; Yamashita Y; Shioi G; Hinoi E
J Bone Miner Res; 2016 Mar; 31(3):573-84. PubMed ID: 26391411
[TBL] [Abstract][Full Text] [Related]
17. Advances in Runx2 regulation and its isoforms.
Li YL; Xiao ZS
Med Hypotheses; 2007; 68(1):169-75. PubMed ID: 16901655
[TBL] [Abstract][Full Text] [Related]
18. Polycomb PRC2 complex mediates epigenetic silencing of a critical osteogenic master regulator in the hippocampus.
Aguilar R; Bustos FJ; Saez M; Rojas A; Allende ML; van Wijnen AJ; van Zundert B; Montecino M
Biochim Biophys Acta; 2016 Aug; 1859(8):1043-55. PubMed ID: 27216774
[TBL] [Abstract][Full Text] [Related]
19. Pax2 is essential for proliferation and osteogenic differentiation of mouse mesenchymal stem cells via Runx2.
Lu M; Guo S; Hong F; Zhang Y; Yuan L; Ma C; Ma J
Exp Cell Res; 2018 Oct; 371(2):342-352. PubMed ID: 30144446
[TBL] [Abstract][Full Text] [Related]
20. miR‑217 inhibits osteogenic differentiation of rat bone marrow‑derived mesenchymal stem cells by binding to Runx2.
Zhu YL; Wang S; Ding DG; Xu L; Zhu HT
Mol Med Rep; 2017 May; 15(5):3271-3277. PubMed ID: 28339007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
